Outlook Therapeutics Total Liabilities

Outlook Therapeutics (OTLK) currently reports a total liabilities of $51T as of March 2026. That compares with $52T in the prior-year period — down 1.3% year over year. Use the charts on this page to explore Outlook Therapeutics's total liabilities history and peer comparisons.

Outlook Therapeutics's total liabilities decreased from $52T to $51T — a 1.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Outlook Therapeutics reported $51T in total liabilities as of March 2026. That compares with $52T in the prior-year period — down 1.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $51T, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Outlook Therapeutics, and consider following OTLK for alerts when major investors trade the stock.

Outlook Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $51T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OTLK with unrelated industries.